glp 1 alcoholism GLP-1 Anti-Obesity Rx and Alcohol and Substance Use Disorders An inhibitory GLP-1 circuit in

J Neuroendocrinol (2018) 30(3):e12572

Acta Pharmacol Sin (2022) 43(4):96376

This means that patients who have already been started on Wegovy or Zepbound for weight management in recent months may be eligible to transition to the Bridge without re-starting from scratch but the prescriber must complete a retrospective attestation of the qualifying BMI and clinical condition at the time of initial prescription

GLP-1s for weight loss are approved for a much broader population: people who have obesity or are overweight with one related condition

GABAB receptor- and metabotropic glutamate receptor-dependent cooperative long-term potentiation of rat hippocampal GABAA synaptic transmission

This can be particularly beneficial for athletes and active individuals looking to enhance performance and recovery